carbazilquinone has been researched along with Refractory Anemia in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yonekura, S | 1 |
| Nagao, T | 1 |
| Arimori, S | 1 |
1 other study available for carbazilquinone and Refractory Anemia
| Article | Year |
|---|---|
Essential thrombocythemia developing into refractory anemia and complicated by acute myeloid leukemia.
Topics: Aged; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cytarabin | 1992 |